Big Pharma rescues flailing 'cancer vaccine' company with $300 million buyout
The deal comes four months after Immune Design Corp. halted its lead cancer vaccine trial and restructured its drug development plans. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 21, 2019 Category: Biotechnology Authors: Casey Coombs Source Type: news

Big Pharma rescues flailing 'cancer vaccine' company with $300 million buyout
The deal comes four months after Immune Design Corp. halted its lead cancer vaccine trial and restructured its drug development plans. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 21, 2019 Category: American Health Authors: Casey Coombs Source Type: news

Drug giant Merck acquires Seattle biotech Immune Design for $300 million
The deal comes four months after Immune Design Corp. halted its lead cancer vaccine trial and restructured its drug development plans. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - February 21, 2019 Category: Health Management Authors: Casey Coombs Source Type: news

Drug giant Merck acquires Seattle biotech Immune Design for $300 million
The deal comes four months after Immune Design Corp. halted its lead cancer vaccine trial and restructured its drug development plans. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 21, 2019 Category: Biotechnology Authors: Casey Coombs Source Type: news

HPV Infections in Decline, Thanks to Vaccines
The new study finds that rates of infection with HPV 16 or 18 -- the two strains most heavily implicated in cervical cancer -- have markedly declined between 2008 and 2014. (Source: WebMD Health)
Source: WebMD Health - February 21, 2019 Category: Consumer Health News Source Type: news

Drug giant Merck acquires Seattle biotech Immune Design for $300 million
The deal comes four months after Immune Design Corp. halted its lead cancer vaccine trial and restructured its drug development plans. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 21, 2019 Category: Pharmaceuticals Authors: Casey Coombs Source Type: news

HPV Infections Most Tied to Cancer Are in Decline, and Vaccines May Be Why
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 21, 2019 Category: Cancer & Oncology Tags: Gynecology, Infections, Oncology, News, Source Type: news

Most Nations May Be Rid of Cervical Cancer By 2100
THURSDAY, Feb. 21, 2019 -- Rapid expansion of HPV vaccination and cervical cancer screening could eliminate the cancer as a major health problem in many countries by the end of the century, a new study claims. HPV (human papillomavirus) causes most... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 21, 2019 Category: General Medicine Source Type: news

HPV Infections Most Tied to Cancer Are in Decline, and Vaccines May Be Why
THURSDAY, Feb. 21, 2019 -- Infections with two strains of the sexually transmitted human papillomavirus (HPV) are showing marked declines among American women, and rising vaccination rates could be driving the trend. That's the finding from a new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 21, 2019 Category: General Medicine Source Type: news

HPV Infections Most Tied to Cancer Are in Decline, and Vaccines May Be Why
Title: HPV Infections Most Tied to Cancer Are in Decline, and Vaccines May Be WhyCategory: Health NewsCreated: 2/21/2019 12:00:00 AMLast Editorial Review: 2/21/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 21, 2019 Category: Cancer & Oncology Source Type: news

Rates for two types of cancer-linked HPV strains have plummeted since the HPV vaccine was rolled out
A new study from the CDC found cases of women positive for HPV types 16 and 18 - responsible for about 70% of cervical cancers worldwide - fell by more than 30% from 2008 to 2014. (Source: the Mail online | Health)
Source: the Mail online | Health - February 21, 2019 Category: Consumer Health News Source Type: news

Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine
(American Association for Cancer Research) An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus (HPV) that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease. The study offers evidence that HPV vaccination reduced the incidence of infections that can lead to cervical cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2019 Category: Cancer & Oncology Source Type: news

NHS prescription charge to rise to £9
20p rise on single prescription fee Related items fromOnMedica NICE rejects breast cancer drug for NHS funding Wales cancer spend at record high JCVI recommends universal HPV vaccination Promise to end new HIV transmissions in England by 2030 NICE recommends Herceptin for gastric cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 21, 2019 Category: UK Health Source Type: news

HPV Infections Most Tied to Cancer Are in Decline, and Vaccines May Be Why
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - February 21, 2019 Category: Cancer & Oncology Source Type: news

Review of NHS screening services underway
Health professionals urged to comment on review Related items fromOnMedica NHS cancer screening programmes set for major review Third of emergency cancer presenters never saw GP Experts call for wider HPV vaccination Cancer strategies failed to improve one-year survival Cancer diagnosis via screening offers best outcomes (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 21, 2019 Category: UK Health Source Type: news

Cervical cancer will be 'ELIMINATED by 2100' thanks to life-saving HPV vaccine and improved testing
Researchers from the Cancer Council New South Wales in Sydney, Australia, made the prediction - which could see 1,000 British women saved from the disease annually. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2019 Category: Consumer Health News Source Type: news

Cervical cancer could be eliminated in most countries by 2100 – research
Millions of cases could be prevented with high HPV vaccine and screening coverageCervical cancer could be effectively eliminated in most countries around the world by the end of the 21st century, according to research.The HPV (human papilloma virus) vaccine, which protects against the virus that causes most cases, has dramatically reduced incidences of cervical cancer wherever uptake has been high. There are hopes that the jab given to young girls, together with occasional HPV screening, could end the scourge of a disease that kills more than 300,000 women globally every year.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 20, 2019 Category: Science Authors: Sarah Boseley Health editor Tags: Cervical cancer HPV vaccine Health Society Vaccines and immunisation Biology Science World news World Health Organization Australia news Europe Japan Asia Pacific Source Type: news

The Lancet Oncology: Rapid scale-up of HPV vaccine and screening could prevent up to 13 million cases of cervical cancer by 2050
(The Lancet) Cervical cancer could be eliminated as a public health problem in most countries by the end of the century by rapid expansion of existing interventions, according to a modelling study published in The Lancet Oncology journal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 19, 2019 Category: Cancer & Oncology Source Type: news

FDA goes after California stem cell doc for unapproved breast implant device
The FDA this week sent a warning letter to a Beverly Hills, Calif.-based surgeon for their marketing of an unapproved implantable device, dubbed the Pocket Protector, which the surgeon claims can prevent and treat capsular contracture, or scar tissue tightening, during breast implant procedures. In its letter, the federal watchdog also accuses the surgeon, Dr. Mark Berman, of “significant deviations from the FDA’s quality system requirements and current good manufacturing practices,” including charges related to the sterility of implantable devices. “This is not the first time the FDA has notified D...
Source: Mass Device - February 15, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cosmetic/Aesthetic Featured Food & Drug Administration (FDA) Stem Cells Source Type: news

‘Bring back our #ChildHoodDiseases,’ White House official’s wife says as she criticizes vaccines
Darla Shine, the wife of White House communications director Bill Shine, said on Twitter that childhood diseases, such as measles, “keep you healthy & fight cancer.” (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - February 15, 2019 Category: Consumer Health News Authors: Lindsey Bever Source Type: news

Immune stimulant molecule shown to prevent cancer
(University of Louisville) An immune checkpoint molecule developed for cancer immunotherapy also protects against future development of multiple types of cancer when administered by itself. The recombinant protein molecule SA-4-1BBL has been used to enhance the therapeutic efficacy of cancer vaccines with success in pre-clinical animal models. Surprisingly, when the researchers treated normal, healthy mice with SA-4-1BBL alone, the mice were protected when the researchers later exposed them to different types of tumor cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 15, 2019 Category: International Medicine & Public Health Source Type: news

Young cancer survivor fears anti-vax parents put sick kids at risk
Rhett Krawitt's immune system was unable to handle vaccines because he was going through treatment for leukemia. (Source: ABC News: Health)
Source: ABC News: Health - February 14, 2019 Category: Consumer Health News Tags: Health Source Type: news

‘Bring back our #ChildHoodDiseases:’ White House communications director’s wife criticizes vaccines
Darla Shine, the wife of White House communications director Bill Shine, said on Twitter that childhood disease, such as measles, “keep you healthy & fight cancer.” (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - February 14, 2019 Category: Consumer Health News Authors: Lindsey Bever Source Type: news

‘Bring back our #ChildHoodDiseases’: White House communications director’s wife criticizes vaccines.
Darla Shine, the wife of White House communications director Bill Shine, said on Twitter that childhood disease, such as measles, “keep you healthy & fight cancer.” (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - February 14, 2019 Category: Consumer Health News Authors: Lindsey Bever Source Type: news

Sexually transmitted infections are on the rise. Here ’s what you need to know to protect yourself
UCLA Health Rates of sexually transmitted diseases have risen for the past four years to record highs in the United States, according to the Centers for Disease Control and Prevention ’slatest analysis. In California, the state health departmentfound that the number of people diagnosed with syphilis, gonorrhea or chlamydia in 2017 was 45 percent higher than five years prior.These sorts of statistics may spark a fear that there ’s little we can do to protect ourselves — but that’s not the full story.Dr. Leena Nathan, an obstetrician/gynecologist at UCLA Health-Westlake Village, consults with peo...
Source: UCLA Newsroom: Health Sciences - February 14, 2019 Category: Universities & Medical Training Source Type: news

Young cancer survivor fears anti-vax parents are putting sick kids at risk
Rhett Krawitt's immune system was unable to handle vaccines because he was going through treatment for leukemia. (Source: ABC News: Health)
Source: ABC News: Health - February 14, 2019 Category: Consumer Health News Tags: Health Source Type: news

Decoding the human immune system
(Human Vaccines Project) For the first time ever, researchers are comprehensively sequencing the human immune system, which is billions of times larger than the human genome. In a new study published in Nature from the Human Vaccines Project, scientists have sequenced a key part of this vast and mysterious system -- the genes encoding the circulating B cell receptor repertoire. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 13, 2019 Category: Cancer & Oncology Source Type: news

Preventive Care Gets Short Shrift in Inflammatory Bowel Disease
(MedPage Today) -- Vaccines, skin cancer, mental health not often discussed at visits (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - February 12, 2019 Category: Gastroenterology Source Type: news

For recurrent glioblastoma, immunotherapy before surgery appears to help more than afterward
A UCLA-led study suggests that for people with recurrent glioblastoma, administering an immunotherapy drug before surgery is more effective than using the drug afterward.In recent years, immunotherapy drugs, which harness the body ’s immune system to destroy cancer cells, have been shown to be helpful in treating people with advanced or metastatic cancer. But the drugs have yet to show any benefit in helping people with glioblastoma, an aggressive and deadly form of brain cancer. On average, most people with recurrent gliob lastoma live for just six to nine months.The study, published today in Nature Medicine, was co...
Source: UCLA Newsroom: Health Sciences - February 11, 2019 Category: Universities & Medical Training Source Type: news

Cervical screening intervals should be extended
Study supports a switch to HPV screening with five-year intervals Related items fromOnMedica The HPV vaccine, ten years on The risk factors for cervical cancer Screening programmes in England fail to meet standard uptake targets Home samples for cervical screening tests could boost uptake Thousands more women affected by Capita cervical screen blunder (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 7, 2019 Category: UK Health Source Type: news

Trump Wants to End HIV Within 10 Years. Here ’s What That Would Take, According to Experts
About 1.1 million Americans currently live with HIV, and approximately 40,000 are infected each year, according to federal data. But in his State of the Union address, President Donald Trump promised to “eliminate the HIV epidemic in the United States within 10 years” — a plan that hinges on a multi-agency push for better diagnosis, treatment and prevention in at-risk communities, health officials said Wednesday. Trump introduced the plan during his annual address on Tuesday but offered few details. Health officials fleshed out the plan during a call with reporters on Wednesday. The initiative will be ove...
Source: TIME: Health - February 6, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime HIV/AIDS onetime Source Type: news

WHO and vaccine group back "critical" cervical cancer shots
(This Feb. 4 story corrects seventh para to say Merck's Gardasil vaccine targets nine (not four) strains of HPV) (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Canine Bone Cancer Vaccine Hints at a Human Version
TUESDAY, Feb. 5, 2019 -- An experimental vaccine for bone cancer in dogs could offer a road map for a human version of the treatment, researchers report. More than 10,000 cases of bone cancer in dogs occur in the United States each year. But the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 5, 2019 Category: General Medicine Source Type: news

Canine Bone Cancer Vaccine Hints at a Human Version
Title: Canine Bone Cancer Vaccine Hints at a Human VersionCategory: Health NewsCreated: 2/5/2019 12:00:00 AMLast Editorial Review: 2/5/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 5, 2019 Category: Cancer & Oncology Source Type: news

Canine Bone Cancer Vaccine Hints at a Human Version
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 5, 2019 Category: Cancer & Oncology Source Type: news

The disturbing link between vaccines and pediatric cancer
(Natural News) Any illness in a child is distressing, and when it’s a life-threatening disease like cancer it is absolutely devastating to the entire family. Sadly, pediatric cancer diagnoses are on the increase, with about 15,300 kids being diagnosed with some form of cancer each year. One in eight of these children will not survive. Although... (Source: NaturalNews.com)
Source: NaturalNews.com - February 4, 2019 Category: Consumer Health News Source Type: news

Customized Cancer Vaccines Based on Individual Patients ’ DNA Could Soon Be a Reality, Might Require Diagnostic Support from Anatomic Pathology Labs
Pharmaceutical developers are combining genetic sequencing and precision medicine to create new drug therapies and cancer treatments designed for specific patients Most anatomic pathologists are aware of the rapid advances in the field of cancer immunotherapy—sometimes also called immune-oncology. This is an area of healthcare where precision medicine and personal genetics become crucial elements in […] (Source: Dark Daily)
Source: Dark Daily - February 4, 2019 Category: Laboratory Medicine Authors: Jude Tags: Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Uncategorized Source Type: news

WHO and vaccine group back 'critical' cervical cancer shots
LONDON - A vaccine given to girls to protect them against a virus that causes cervical cancer is a "critical" health tool and access to it should be scaled up as swiftly as possible, especially in poorer countries, cancer experts said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - February 4, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA sets March dates for microbiology, neurology device panel meetings
The FDA this week set two new March dates for public medical device advisory committee meetings, the first to discuss microbiology devices and the second to discuss a specific neurological device, according to official FDA releases. In the microbiology devices panel meeting, slated to be held March 8, a committee of microbiology device experts will discuss and make recommendations regarding novel or alternative approaches to clinical studies and devices intended to detect Human Papillomavirus nucleic acid, according to the release. “These approaches will take into consideration scientific data generated since the app...
Source: Mass Device - January 31, 2019 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Featured Food & Drug Administration (FDA) Neurological Regulatory/Compliance neuronix Source Type: news

Personalized Vaccine to be Tested in Patients with Kidney Cancer
Researchers at the Dana-Farber Cancer Institute are working to develop a vaccine for the treatment of renal cell cancer.01/30/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 30, 2019 Category: Urology & Nephrology Source Type: news

Immunotherapy: A Glimmer of Hope for Prostate Cancer Immunotherapy: A Glimmer of Hope for Prostate Cancer
Immune checkpoint inhibitors, PARP inhibitors, and vaccines may soon alter the landscape of immunotherapy for prostate cancer.Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 29, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

SU2C awards 2019 Laura Ziskin Prize in Translational Research
(Stand Up To Cancer) Stand Up To Cancer awarded the 2019 Laura Ziskin Prize in Translational Research ($250,000 for one year) to Drs. Silvia Formenti of Weill Cornell Medicine Sandra and Edward Meyer Cancer Center and Heather McArthur of Cedars Sinai to support collaboration using radiation and immunotherapy pre-operatively to help the body create its own vaccine to fight breast cancer, working with immunologists, bioinformatics specialists and biostatisticians. A clinical trial is in development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2019 Category: Cancer & Oncology Source Type: news

Still Too Few Teens Getting the HPV Vaccine
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - January 29, 2019 Category: Cancer & Oncology Source Type: news

Researchers Find Way For Chickens To Lay Eggs Filled With Cancer-Killing Drugs
BOSTON (CBS) – Researchers in Scotland say they have found a way to have chickens lay eggs filled with medicine. It’s a method that could make some drugs much more affordable. Scientists at The University of Edinburgh have genetically modified the birds to produce human proteins in their eggs that boost the immune system. Now, the chickens are laying eggs containing cancer-killing drugs. Researchers in Scotland have genetically modified chickens to produce human proteins in their eggs (WBZ-TV) “In the past, making these transgenic animals has been very inefficient very expensive and difficult,” says...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 28, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Cancer Dr. Mallika Marshall Source Type: news

New precision medicine procedure fights cancer, advances treatment for pets and humans
(University of Missouri-Columbia) In a first-of-its-kind study, scientists at the University of Missouri have helped advance a patient-specific, precision medicine treatment for bone cancer in dogs. By creating a vaccine from a dog's own tumor, scientists worked with ELIAS Animal Health to target specific cancer cells and avoid the toxic side effects of chemotherapy, while also opening the door for future human clinical trials. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 28, 2019 Category: International Medicine & Public Health Source Type: news

HPV vaccine take-up varies widely
Thousands of girls did not get full immunisation for HPV, which can cause cervical cancer, at school. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 25, 2019 Category: Consumer Health News Source Type: news

Anticancer immunity through tumor antigen identification & conversion to DNA vaccines
(The Wistar Institute) Wistar scientists and collaborators demonstrated the utility of an optimized synthetic DNA vaccine platform for rapidly inducing immunity against unique combinations of tumor neoantigens. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 24, 2019 Category: Cancer & Oncology Source Type: news

Cervical Cancer Screenings Save Lives. So Why Aren ’t More Women Getting Them?
The vast majority of cancers do not have one obvious cause, making them complex both to understand and treat. Cervical cancer is one of the few exceptions: “Virtually all” cases are caused by human papillomaviruses (HPV), according to the National Cancer Institute (NCI). Armed with this knowledge, experts have for decades stressed the importance of regular cervical cancer screenings, which can catch HPV infections and related abnormalities before they develop into deadly disease. And yet many women still don’t get tested as much as they should. The screening rate isn’t entirely clear. A study publis...
Source: TIME: Health - January 22, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Artificial Intelligence Cancer healthytime Life Reinvented Source Type: news

Vaccine and Chemotherapy Combo Shows Promise for Mesothelioma
Mesothelioma patients showed an impressive immune response to TroVax, a novel cancer vaccine, when it was combined with standard chemotherapy in a recent clinical trial. Researchers from Cardiff University in the United Kingdom conducted the study that was published by the journal OncoImmunology. TroVax is a laboratory engineered virus designed to target the human protein 5T4. A mutated form of 5T4 is found in almost all mesothelioma tumors, including the sarcomatoid subtype, the most difficult to treat. The phase II clinical trial produced a disease control rate of 87 percent, more than double the rate of a previous stud...
Source: Asbestos and Mesothelioma News - January 22, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Messages for Increasing Parental Confidence in HPV Vaccine ID'd
TUESDAY, Jan. 22, 2019 -- Providing information on the benefits of vaccination, including cancer prevention, and avoiding expressing urgency to vaccinate can increase parent confidence in human papillomavirus (HPV) vaccination, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 22, 2019 Category: Pharmaceuticals Source Type: news